rs145449046

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_000492.4(CFTR):ā€‹c.2374C>Gā€‹(p.Arg792Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000263 in 1,521,040 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R792Q) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.000046 ( 0 hom., cov: 32)
Exomes š‘“: 0.000024 ( 0 hom. )

Consequence

CFTR
NM_000492.4 missense

Scores

6
6
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:10

Conservation

PhyloP100: 0.616
Variant links:
Genes affected
CFTR (HGNC:1884): (CF transmembrane conductance regulator) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CFTRNM_000492.4 linkuse as main transcriptc.2374C>G p.Arg792Gly missense_variant 14/27 ENST00000003084.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CFTRENST00000003084.11 linkuse as main transcriptc.2374C>G p.Arg792Gly missense_variant 14/271 NM_000492.4 P2P13569-1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152146
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000127
AC:
23
AN:
181308
Hom.:
0
AF XY:
0.000157
AC XY:
15
AN XY:
95510
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000945
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000226
Gnomad OTH exome
AF:
0.000241
GnomAD4 exome
AF:
0.0000241
AC:
33
AN:
1368778
Hom.:
0
Cov.:
32
AF XY:
0.0000268
AC XY:
18
AN XY:
671288
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000944
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000281
Gnomad4 OTH exome
AF:
0.0000355
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152262
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74436
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000457
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000642
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000994
AC:
12
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cystic fibrosis Uncertain:4
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 31, 2023The p.R792G variant (also known as c.2374C>G), located in coding exon 14 of the CFTR gene, results from a C to G substitution at nucleotide position 2374. The arginine at codon 792 is replaced by glycine, an amino acid with dissimilar properties. In a study of 42 men with congenital bilateral absence of the vas deferens, this variant was detected in one individual with another missense variant, p.R766M, on the other allele (Ravnik-Glavac M et al. Hum. Hered.;50:318-9). In vitro studies demonstrated that the variant significantly reduces chloride current and open probabilities of the channel, but still retains approximately 50% of channel activity (Vankeerberghen A et al. Hum. Mol. Genet., 1998 Oct;7:1761-9). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Uncertain significance, criteria provided, single submitterclinical testingGenome-Nilou LabSep 05, 2021- -
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Uncertain significance, criteria provided, single submitterclinical testingInvitaeOct 05, 2022This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 792 of the CFTR protein (p.Arg792Gly). This variant is present in population databases (rs145449046, gnomAD 0.09%). This missense change has been observed in individual(s) with CFTR-related conditions (PMID: 9736778). ClinVar contains an entry for this variant (Variation ID: 35840). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CFTR protein function. Experimental studies have shown that this missense change affects CFTR function (PMID: 9736778). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMay 10, 2019The CFTR c.2374C>G; p.Arg792Gly variant (rs145449046) has been described in the compound heterozygous state in one individual with congenital bilateral absence of the vas deferens (Ravnik-Glavac 2000). It is reported as a variant of uncertain significance in ClinVar (Variation ID: 35840) and observed in the Latino population at an overall frequency of 0.095% (21/22002 alleles) in the Genome Aggregation Database. The arginine at codon 792 is highly conserved, and computational algorithms (SIFT, PolyPhen-2) predict that this variant is deleterious. In vitro functional studies of the variant protein demonstrate reduced chloride current and disruption of a consensus recognition site used for CFTR activation (Vankeerberghen 1998). However, due to limited clinical information regarding this variant, its clinical significance cannot be determined with certainty. References: Ravnik-Glavac M et al. Two novel missense mutations (R766M and R792G) in exon 13 of the CFTR gene in a patient with congenital bilateral absence of the vas deferens. Hum Hered. 2000 Sep-Oct;50(5):318-9. Vankeerberghen A et al. Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator. Hum Mol Genet. 1998 Oct;7(11):1761-9. -
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJun 28, 2023Variant summary: CFTR c.2374C>G (p.Arg792Gly) results in a non-conservative amino acid change located in the CFTR regulator domain (IPR025837) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00013 in 181538 control chromosomes, predominantly at a frequency of 0.00095 within the Latino subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in CFTR causing Congenital Bilateral Absence Of The Vas Deferens or Cystic Fibrosis, allowing no conclusion about variant significance. c.2374C>G has been reported in the literature in individuals affected with Congenital Bilateral Absence Of The Vas Deferens and Cystic Fibrosis and has been subsequently cited by others (example, Vankeerberghen_1998, Ravnik-Glavac_2000, Dorfman_2010, Green_2010, Rowntree_2003, de Souza_2018, Yang_2015). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 30%-50% of normal activity for whole cell chloride currents measured in Xenopus laevis oocytes (Vakneerberghen_1998). The following publications have been ascertained in the context of this evaluation (PMID: 20059485, 20932301, 25735457, 10878476, 12940920, 9736778, 26277102, 29216686). Nine submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 12, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxAug 22, 2019In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 29216686, 20932301, 9736778, 12940920, 26277102, 10878476) -
Hereditary pancreatitis Uncertain:1
Uncertain significance, criteria provided, single submittercurationSema4, Sema4May 04, 2021- -
Cystic fibrosis;C0238339:Hereditary pancreatitis;C0403814:Congenital bilateral aplasia of vas deferens from CFTR mutation;C2749757:Bronchiectasis with or without elevated sweat chloride 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMay 09, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Pathogenic
0.16
D
BayesDel_noAF
Pathogenic
0.39
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.76
D;.;D;.
Eigen
Benign
-0.052
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.31
N
LIST_S2
Uncertain
0.91
D;D;D;D
M_CAP
Pathogenic
0.29
D
MetaRNN
Uncertain
0.43
T;T;T;T
MetaSVM
Pathogenic
0.90
D
MutationAssessor
Uncertain
2.3
M;.;.;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.34
T
PROVEAN
Uncertain
-3.2
D;.;D;.
REVEL
Pathogenic
0.66
Sift
Benign
0.080
T;.;D;.
Sift4G
Pathogenic
0.0010
D;.;D;.
Polyphen
0.99
D;.;.;.
Vest4
0.92
MVP
0.99
MPC
0.0057
ClinPred
0.42
T
GERP RS
0.93
Varity_R
0.28
gMVP
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145449046; hg19: chr7-117232595; API